Seattle, WA - Tom Ranken, CEO and co-founder of VizX Labs, LLC today announced the addition to its board of directors of three senior executives who have founded highly profitable cutting-edge high-tech companies, developed novel therapeutic approaches to the treatment of serious diseases, and led M&A activity for hospitals in crisis. They include Jeremy Jaech, founder of Poseidon Ventures; Dr. Bruce Montgomery, CEO of Corus Pharma, Inc.; and Ray Crerand, recently retired CEO of Providence Everett Medical Center.

"Can you imagine the excitement this firm experienced when it learned that these eminent men of vision had agreed to join our CTO, Bob Cottingham, and myself on our board to create a whole new product category?" said Ranken.

Jeremy Jaech is perhaps best known as co-founder of Aldus and Visio Corporations. In 1984, Mr. Jaech and four others founded Aldus Corporation. In 1985, Aldus introduced PageMaker® desktop publishing software for the Macintosh, a program that allowed users to mix type and graphics on the same page. PageMaker coupled with the Apple LaserWriter laser printer launched an era of desktop publishing. Mr. Jaech managed the development of all Aldus products created through 1989.

In 1990, Mr. Jaech and two others founded Visio Corporation where he served the corporation as president and CEO. The company introduced software for information-technology professionals and engineers that enabled users to diagram, visualize, document, and share ideas including flowcharts, organization charts, and office layouts. Microsoft acquired the Company in 2000 and Mr. Jaech became Vice President-Visio Division for Microsoft Corporation. Jaech was raised in Richland, WA, earned degrees in math and computer science at the University of Washington, and after receiving his BA, he was employed by Battelle's Pacific Northwest Laboratories and then at Boeing performing computer-aided design R&D in anticipation of the 777 program.

Bruce Montgomery, MD, brings a record of breakthrough biotechnology development, novel business approaches and management expertise to the board of VizX Labs. He is CEO of Corus Pharma, Inc., a venture-funded Seattle drug development company that is focused on the discovery of novel therapeutics for infectious and respiratory diseases.

Prior to founding Corus, Dr. Montgomery was executive vice president of R&D for Pathogenesis where in 1998 his leadership in the development and regulatory approval of tobramycin for the treatment of cystic fibrosis earned him an FDA Commissioners Special Citation. Dr. Montgomery was one of three people responsible for raising $160 million in IPO and secondary offerings for the company, and was also a member of the team that negotiated the sale of the company to Chiron for $700 million in September 2000.

Dr. Montgomery received the Patriotic Civilian Service Award from the Secretary of the Army in 1997. His academic career included Assistant Professorships at both UCSF and SUNY Stony Brook, where he directed the ICU. Dr. Montgomery is a board-certified internist and pulmonologist who received his MD and a BS in Chemistry from the University of Washington.

Ray Crerand recently retired as the CEO of Providence Everett Medical Center, the tenth largest hospital in Washington. He has been a leading figure for over 20 years in hospital management in the Northwest and nationally. He is a former chairman of the Washington State Hospital Association and a board member of the American College of Healthcare Executives. Mr. Crerand served as the CEO of Everett's Providence Hospital from 1988 to 1993. Providence merged with General Hospital Medical Center in March 1994. He played a crucial role in bringing the two formerly fierce competitors together, and as CEO guided the hospital through tumultuous labor troubles and an employee strike in 2000.

VizX Labs, LLC develops products which enable life scientists to readily incorporate sophisticated data management and computational analysis into their research efforts, resulting in improved quality and productivity in experiment design and decision-making processes.

Editor's note: The VizX Labs newsroom is archived at: http://www.vizxlabs.com/newsroom.html